Ginkgo Bioworks Announces Date of Second Quarter 2022 Results Presentation
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) is scheduled to present its second quarter 2022 results on August 15, 2022, at 4:30 p.m. ET. The session will review the company's business performance for the quarter ending June 30, 2022. Investors can access details and the webcast link on Ginkgo's investor relations website. Additionally, a replay will be available post-event. Ginkgo's platform focuses on programming cells for applications in various sectors including food, agriculture, and pharmaceuticals, and has been active in COVID-19 response efforts.
Positive
- Scheduled presentation for Q2 2022 results indicates ongoing transparency and investor communication.
- Engagement with investors through Q&A suggests a proactive approach to stakeholder relations.
Negative
- None.
News Market Reaction – DNA
In the trading session that priced this news, DNA gained 5.54%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Presentation and Q&A session scheduled for post-market on Monday, August 15, 2022
BOSTON, Aug. 8, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2022, on Monday, August 15, 2022, beginning at 4:30 p.m. ET.
The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit https://www.ginkgobioworks.com/.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-second-quarter-2022-results-presentation-301601471.html
SOURCE Ginkgo Bioworks